Pathway Name | Organism |
---|---|
MAPK1 (ERK2) activation | Homo sapiens |
MAPK3 (ERK1) activation | Homo sapiens |
Other interleukin signaling | Homo sapiens |
Potential therapeutics for SARS | Homo sapiens |
RAF/MAP kinase cascade | Homo sapiens |
Regulation of IFNA/IFNB signaling | Homo sapiens |
Regulation of IFNG signaling | Homo sapiens |
SARS-CoV-2 activates/modulates innate and adaptive immune responses | Homo sapiens |
Signaling by CSF3 (G-CSF) | Homo sapiens |
DO ID | Disease Name | Source |
---|---|---|
DOID:10283 | prostate cancer | |
DOID:10534 | stomach cancer | |
DOID:1380 | endometrial cancer | |
DOID:2394 | ovarian cancer | |
DOID:3908 | lung non-small cell carcinoma | |
DOID:4074 | pancreatic adenocarcinoma | |
DOID:5603 | T-cell acute lymphoblastic leukemia | |
DOID:684 | hepatocellular carcinoma | |
DOID:9256 | colorectal cancer |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025